IP Library Granted Patent US 10,850,235
Granted Patent B2
US 10,850,235 · App. 15/177,638 · Granted Dec 1, 2020

Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow

Inventors: Emily Rolfes Meyering (St. Louis Park, MN); Gary Seim (Minneapolis, MN); Abhi Vase (Los Altos Hills, CA); Ben Krehbiel (Lake City, MN); Blake Hedstrom (Minneapolis, MN); Aaron McCabe (Edina, MN)
Assignee: MINNETRONIX, INC.
B01D61/32A61M1/0094B01D61/145B01D61/147A61M2202/0464A61M2205/3334A61M2205/75A61M2206/11A61M2230/005B01D2311/12B01D2311/16B01D2315/10B01D2317/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,850,235
App. No.
15/177,638
Granted
Dec 1, 2020
Kind
B2
Abstract

Systems and methods for filtering materials from biologic fluids are discussed. Embodiments may be used to filter cerebrospinal fluid (CSF) from a human or animal subject. The method may include the steps of withdrawing fluid comprising CSF, filtering the volume into permeate and retentate by passing the fluid through a tangential flow filter, and returning the permeate to the subject. During operation of the system, various parameters may be modified, such as flow rate.

Claims (31)

1. A method for filtering materials from cerebrospinal fluid (CSF) of a human or animal subject, the method comprising:

withdrawing a withdrawal volume of fluid comprising CSF from a CSF-containing space of the subject at a first flow rate using a filtration system, the filtration system operating according to a set of operation parameters;

filtering the withdrawal volume of fluid into permeate and retentate using a tangential flow filter of the filtration system;

returning a returned volume of the permeate to the CSF-containing space lumen of the subject at a second flow rate;

determining a difference between the withdrawal volume and the returned volume; and

updating a parameter of the set of operation parameters when the difference between the withdrawal volume and the returned volume exceeds a predetermined threshold.

2. The method of claim 1 , wherein the first filtration system is in fluid connection with the CSF-containing space of the subject via a multi-lumen catheter inserted at least partially within the space.

3. The method of claim 1 , wherein the parameter of the set of operation parameters comprises the first flow rate and the second flow rate.

4. The method of claim 3 , wherein updating the parameter of the set of operation parameters comprises equalizing the first flow rate and the second flow rate.

5. The method of claim 1 , wherein the threshold is a volume of removed CSF that is predicted to induce a spinal headache.

6. The method of claim 5 , wherein the parameter of the set of operation parameters comprises a flow rate parameter and updating the parameter of the set of operation parameters causes the first and second flow rate to decrease.

7. The method of claim 5 , wherein the subject is a human subject and the withdrawal volume of removed CSF that is predicted to induce a spinal headache is between about 35 milliliters per hour and 45 milliliters per hour.

8. The method of claim 1 , wherein the first flow rate is between approximately 0.04 milliliters per minute and approximately 30 milliliters per minute.

9. The method of claim 1 , further comprising adding a therapeutic agent to the permeate prior to returning the permeate.

10. The method of claim 1 , further comprising adding a volume of artificial CSF to the permeate prior to returning the permeate.

11. The method of claim 1 , wherein determining a difference between the withdrawal volume and the returned volume includes sensing the withdrawal volume and returned volume with a sensor.

12. The method of claim 1 , wherein the filtration system includes a pump and wherein withdrawing a withdrawal volume of fluid comprising CSF from a CSF-containing space of the subject at a first flow rate using a filtration system includes actuating the pump.

13. A method for filtering cerebrospinal fluid (CSF), the method comprising:

withdrawing a volume of CSF from a patient at a first flow rate;

filtering the volume of fluid with a filtration system;

wherein filtering the volume of fluid includes filtering the volume into a permeate and a retentate;

returning the permeate to the patient at a second flow rate;

calculating a difference between the first flow rate and the second flow rate; and

modifying the first flow rate, the second flow rate, or both when the difference between the first flow rate and the second flow rate exceeds a predetermined threshold.

14. A method for filtering cerebrospinal fluid (CSF), the method comprising:

withdrawing a first volume of CSF from a patient at a first flow rate;

filtering the first volume of fluid with a filtration system;

wherein filtering the first volume of fluid includes filtering the first volume into a permeate volume and a retentate;

returning the permeate volume to the patient at a second flow rate;

determining a difference between the first volume and the permeate volume; and

modifying the first flow rate, the second flow rate, or both when the difference between the first volume and the permeate volume exceeds a predetermined threshold.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2025
From: MINNETRONIX NEURO, INC.
To: PHARAOH NEURO, INC.
Reel/Frame 073429/0607 →
RELEASE OF PATENT SECURITY AGREEMENT - REEL/FRAME 054795/0607, SUPPLEMENTAL PATENT SECURITY AGREEMENT - REAL/FRAME 056240/0147 AND ASSIGNMENT ID: 885388 Recorded Oct 1, 2025
From: TEXAS CAPITAL BANK, AS AGENT
To: MINNETRONIX MEDICAL, INC.
Reel/Frame 073434/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2025
From: MINNETRONIX, INC.
To: MINNETRONIX NEURO, INC.
Reel/Frame 071588/0980 →
PARTIAL RELEASE OF PATENT SECURITY AGREEMENT - REEL 054795 FRAME 0607; AND REEL 056240 FRAME 0147 Recorded Jun 10, 2025
From: TEXAS CAPITAL BANK, AS ADMINISTRATIVE AGENT
To: MINNETRONIX, INC.; MINNETRONIX NEURO, INC. (F/K/A NEUROFLUIDICS, INC.)
Reel/Frame 071588/0015 →
ASSIGNMENT OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED ON REEL 054795 FRAME 0607 AND SUPPLEMENTAL PATENT SECURITY AGREEMENT RECORDED ON REEL 056240 FRAME 0147 Recorded Mar 13, 2025
From: FIRST HORIZON BANK
To: TEXAS CAPITAL BANK, AS SUCCESSOR AGENT
Reel/Frame 073460/0969 →
SECURITY INTEREST Recorded Jan 4, 2021
From: MINNETRONIX MEDICAL, INC.; MINNETRONIX NEURO, INC.
To: FIRST HORIZON BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 054795/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2016
From: MEYERING, EMILY; VASE, ABHI; SEIM, GARY; KREHBIEL, BEN; HEDSTROM, BLAKE; MCCABE, AARON
To: MINNETRONIX, INC.
Reel/Frame 038862/0917 →
Continuity (2)
Provisional Application 62201287 · Aug 5, 2015
Related Publication 20170035998A1 · Feb 9, 2017
Cited By (1)
US 12,290,785